Increased Bone Volume by Ixazomib in Multiple Myeloma: 3-Month Results from an Open Label Phase 2 Study.
Diaz-delCastillo M, Gundesen MT, Andersen CW, Nielsen AL, Møller HEH, Vinholt PJ, Asmussen JT, Kristensen IB, Nyvold CG, Abildgaard N, Levin Andersen T, Lund T.
Diaz-delCastillo M, et al. Among authors: abildgaard n.
J Bone Miner Res. 2023 May;38(5):639-649. doi: 10.1002/jbmr.4807. Epub 2023 Apr 12.
J Bone Miner Res. 2023.
PMID: 36970780
Free article.
Clinical Trial.